Moreover, celecoxib enhanced the apoptosis of cervical cancer cells in response to DCA, which was revealed by Flow Cytometry analysis of annexin V-FITC (fluorescein isothiocyanate) and PI (prodium iodide) double staining (Figure 2C), Western blot analysis of cleaved PARP (poly ADP-ribose polymerase) and cleaved caspase3 (Figure 2D), and Hoechst staining of apoptotic bodies (Figure 2E). The gene discussed is ANXA5; the disease is cervical cancer.